First-Line Faricimab in Diabetic Macular Edema: Insights from a Real-World Treatment-Naïve Population in Austria. [PDF]
J Clin MedWidmann-Sedlnitzky P +9 more
europepmc +1 more source
Association of systemic inflammatory indices and body mass index with diabetic macular edema in non-proliferative diabetic retinopathy. [PDF]
BMC OphthalmolHarley O +4 more
europepmc +1 more source
Association of vitreous CREG1 with diabetic macular edema response and edema resolution following ranibizumab therapy. [PDF]
Front Med (Lausanne)Zhu L +5 more
europepmc +1 more source
Prognostic Imaging Biomarkers in Diabetic Macular Edema Treated with Anti-VEGF: A Multicenter AI Perspective. [PDF]
Ophthalmol TherParravano M +7 more
europepmc +1 more source
Efficacy and Safety of Anti-vascular Endothelial Growth Factor (VEGF) Agents in Diabetic Macular Edema. [PDF]
CureusKrishnan B V, Kauser N, Priya G, Sm M.
europepmc +1 more source
A review of optimization strategies for deep and machine learning in diabetic macular edema. [PDF]
Front Artif IntellMutawa AM +3 more
europepmc +1 more source
Fluocinolone acetonide implant in diabetic macular edema: sustained benefits and effects of following prior therapy. [PDF]
Int J Retina VitreousNecpal P +3 more
europepmc +1 more source
Efficacy and safety of ranibizumab, aflibercept, and conbercept in the treatment of diabetic macular edema: a retrospective comparative study. [PDF]
Sci RepLiu B, Qiao Q, Dang Y.
europepmc +1 more source
Aflibercept and Brolucizumab in Diabetic Macular Edema: A Focused Review of Efficacy, Safety, and Clinical Considerations. [PDF]
BiomedicinesDascalu AM +9 more
europepmc +1 more source